Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.48 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PLA2G2C | Q5R387 | 3/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8536165 | 1.00 | USP2 (0.51) | USP2HTTCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL8345106 | 1.00 | USP2 (0.51) | USP2HTTCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL2390593 | 0.86 | FFAR4 (0.49) | MAPTFFAR4FFAR1MEN1KMT2A | |
| SCHEMBL9509695 | 0.84 | USP2 (0.48) | USP2HTTCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL8080765 | 0.83 | FFAR4 (0.54) | FFAR4FFAR1EPHX2 | |
| SCHEMBL8081193 | 0.83 | FFAR4 (0.54) | FFAR4FFAR1EPHX2 | |
| SCHEMBL8345099 | 0.83 | USP2 (0.51) | USP2HTTCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL8350738 | 0.83 | USP2 (0.51) | USP2HTTCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL10490771 | 0.82 | USP2 (0.54) | USP2HTTCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL2493469 | 0.82 | USP2 (0.44) | USP2HTTCYP1A2CYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150329754-A1 | LIQUID COMPOSITION | DAICEL CORPORATION (JP) | 2015-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150329754-A1 | LIQUID COMPOSITION | ABHD5, NAPEPLD, ELOVL5 | USP2 1639/4885HTT 3919/4885CYP1A2 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.